SK287850B6 - Stable pharmaceutical form of the anti-cancer drug - Google Patents

Stable pharmaceutical form of the anti-cancer drug Download PDF

Info

Publication number
SK287850B6
SK287850B6 SK629-2003A SK6292003A SK287850B6 SK 287850 B6 SK287850 B6 SK 287850B6 SK 6292003 A SK6292003 A SK 6292003A SK 287850 B6 SK287850 B6 SK 287850B6
Authority
SK
Slovakia
Prior art keywords
paclitaxel
solvents
mixture
range
vials
Prior art date
Application number
SK629-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK6292003A3 (en
Inventor
Stanislaw Janicki (Zomrel)
Alicja Maria Janicka (Dedic)
Malgorzata Janicka-Kokitko (Dedic)
Malgorzata Sznitowska
Wladyslaw Karas
Zdislaw Mroczek
Andrzej Tyrala
Iwona Czarnecka
Original Assignee
Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna
Instytut Chemii Organicznej Pan
Akademia Medyczna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna, Instytut Chemii Organicznej Pan, Akademia Medyczna filed Critical Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna
Publication of SK6292003A3 publication Critical patent/SK6292003A3/sk
Publication of SK287850B6 publication Critical patent/SK287850B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK629-2003A 2000-10-31 2001-10-19 Stable pharmaceutical form of the anti-cancer drug SK287850B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL343615A PL203300B1 (pl) 2000-10-31 2000-10-31 Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
PCT/PL2001/000082 WO2002036582A1 (en) 2000-10-31 2001-10-19 Stable pharmaceutical form of an anticancer drug

Publications (2)

Publication Number Publication Date
SK6292003A3 SK6292003A3 (en) 2004-08-03
SK287850B6 true SK287850B6 (sk) 2012-01-04

Family

ID=20077651

Family Applications (1)

Application Number Title Priority Date Filing Date
SK629-2003A SK287850B6 (sk) 2000-10-31 2001-10-19 Stable pharmaceutical form of the anti-cancer drug

Country Status (15)

Country Link
EP (1) EP1363892B1 (pl)
AU (1) AU2002212863A1 (pl)
BG (1) BG65985B1 (pl)
CZ (1) CZ300836B6 (pl)
DE (1) DE60122384T2 (pl)
HK (1) HK1060733A1 (pl)
HU (1) HUP0303089A3 (pl)
LT (1) LT5069B (pl)
PL (1) PL203300B1 (pl)
RU (1) RU2236227C1 (pl)
SI (1) SI21138B (pl)
SK (1) SK287850B6 (pl)
UA (1) UA75620C2 (pl)
WO (1) WO2002036582A1 (pl)
ZA (1) ZA200303276B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050044621A (ko) * 2001-11-30 2005-05-12 브리스톨-마이어스 스큅 컴퍼니 파클리탁셀 용매화물
EP1694660B1 (en) 2003-12-12 2009-04-08 Quiral Quimica Do Brasil Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
AR054215A1 (es) * 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
CN110437179A (zh) * 2019-08-22 2019-11-12 江苏红豆杉药业有限公司 一种紫杉醇单晶晶体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates

Also Published As

Publication number Publication date
HUP0303089A2 (hu) 2003-12-29
CZ20031421A3 (cs) 2004-06-16
SK6292003A3 (en) 2004-08-03
EP1363892A1 (en) 2003-11-26
CZ300836B6 (cs) 2009-08-19
HK1060733A1 (en) 2004-08-20
SI21138A (sl) 2003-08-31
EP1363892B1 (en) 2006-08-16
LT5069B (lt) 2003-11-25
BG65985B1 (bg) 2010-08-31
RU2236227C1 (ru) 2004-09-20
UA75620C2 (en) 2006-05-15
AU2002212863A1 (en) 2002-05-15
PL343615A1 (en) 2002-05-06
LT2003031A (en) 2003-09-25
PL203300B1 (pl) 2009-09-30
BG107764A (bg) 2004-07-30
DE60122384T2 (de) 2007-08-16
HUP0303089A3 (en) 2005-02-28
SI21138B (sl) 2006-10-31
WO2002036582A1 (en) 2002-05-10
ZA200303276B (en) 2004-04-21
DE60122384D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
AU724842B2 (en) Taxane composition and method
CN1169525C (zh) 紫杉烷的药物制剂
US7772274B1 (en) Docetaxel formulations with lipoic acid
KR20140067034A (ko) 카바지탁셀 제제와 이를 제조하는 방법
CZ284080B6 (cs) Injikovatelná kompozice obsahující deriváty skupiny taxanů
SK1594A3 (en) Novel compositions based on taxane class derivatives
EP2903435B1 (en) Non-aqueous taxane nanodispersion formulations and methods of using the same
CN110464846B (zh) 一种美洛昔康组合物、制剂及其制备方法与应用
WO2013022969A1 (en) Docetaxel formulations with lipoic acid
AU702519B2 (en) Parenteral pharmaceutical compositions containing GF120918A
WO2011111070A2 (en) Novel injectable combination
SK287850B6 (sk) Stable pharmaceutical form of the anti-cancer drug
US8476310B2 (en) Docetaxel formulations with lipoic acid
ES2344674B1 (es) Composicion farmaceutica inyectable de taxanos.
KR20080096829A (ko) 정맥내 항바이러스 치료
MXPA97002473A (en) Parenteral pharmaceutical compositions containing gf1209

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20121019